Clinical Trials
489 trialsQuercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Children's Hospital Medical Center, Cincinnati
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Ohio State University Comprehensive Cancer Center
ELSA-FN
Murdoch Childrens Research Institute
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Fred Hutchinson Cancer Center
BMT
Massachusetts General Hospital
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Roswell Park Cancer Institute
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
Memorial Sloan Kettering Cancer Center
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Boston Children's Hospital
BMT CTN 1702
Center for International Blood and Marrow Transplant Research
GLIOPLAK
Centre Henri Becquerel
To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.
Fayoum University
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Thomas Jefferson University
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
Masonic Cancer Center, University of Minnesota
MYELAXAT
University Hospital, Grenoble
PiCASO
Duke University
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Beijing Suncadia Pharmaceuticals Co., Ltd
CARAVAGGIO
Fadoi Foundation, Italy
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Fred Hutchinson Cancer Center
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
Thomas Jefferson University
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.
Jiangsu HengRui Medicine Co., Ltd.
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Thomas Jefferson University
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
Rigshospitalet, Denmark
ORCHARD
University of Aberdeen
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Fred Hutchinson Cancer Center
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
University of Utah
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
AstraZeneca
The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CluPPFeN
University Hospital, Angers
AFFECT-1
Radboud University Medical Center
AFFECT-2
Radboud University Medical Center
MargheRITA
Advice Pharma Group srl
EVAADE
Centre Leon Berard
TRANSPORT
Assistance Publique - Hôpitaux de Paris
AIRPORT-MPN
Ottawa Hospital Research Institute
Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN)
Duke University
Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
ROSIE
Radboud University Medical Center
1703/1801
Medical College of Wisconsin
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
National Cancer Institute (NCI)
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)
AstraZeneca
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Memorial Sloan Kettering Cancer Center
VINO
Swiss Federal Institute of Technology
ICEBERG 1
AstraZeneca